ARWR  230120C00040000

Sold 50% of ARWR $40 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Dakotah

Sold 33% of ARWR $40 Calls

Sold 25% of ARWR $40 Calls

Bought 14% more ARWR $40 Calls

Bought 17% more ARWR $40 Calls

ARWR  221216C00040000

Bought ARWR $40 Calls

Bought 20% more ARWR $40 Calls

Bought 25% more ARWR $40 Calls

Bought 33% more ARWR $40 Calls

Bought 50% more ARWR $40 Calls

Bought 100% more ARWR $40 Calls

ARWR  220218C00065000

Bought 50% more ARWR $65 Calls

Bought 11% more ARWR $65 Calls

Bought 12% more ARWR $65 Calls

Bought 14% more ARWR $65 Calls

Bought 17% more ARWR $65 Calls

Bought 100% more ARWR $65 Calls

Bought ARWR $65 Calls

arrowhead pharmaceuticals is a clinical stage, nasdaq listed (ticker arwr) company developing medicines that treat intractable diseases by silencing the genes that cause them. using a broad portfolio of rna chemistries and efficient modes of delivery, our 

Arrowhead Research Corporation

Bought 3% more ARWR

Bought 4% more ARWR

Sold all ARWR

New position in ARWR

Bought 2% more ARWR

Sold 50% of ARWR

Sold 6% of ARWR

Sold 38% of ARWR

Bought 1% more ARWR